InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (7 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Cooper Ronald Harold Wilfred, Chief Executive Officer. Director active across 3 companies, notably Albireo Pharma, INC.. In total, 14 filings have been logged. Breakdown: 1 buy · 7 sells. Total volume traded: €342k. History available since 17 September 2021. The latest transaction was disclosed on 27 September 2024 (Acquisition). Regulator: SEC (Form 4). The full history is free.
Declarations14 total
10,000 shares@ US$5.70100.0% of flowCommon SharesSEC:0000929638-24-003358:0
Ideal exit: 24 Jun 2025 (T+270)
33,094 sharesCommon StockSEC:0001209191-23-014778:0
195,000 shares0Common StockSEC:0001209191-23-005338:0
195,000 shares0Common StockSEC:0001209191-23-004953:0
1,057 shares@ US$43.806.3% of flowCommon StockSEC:0001209191-23-004448:0
919 shares@ US$19.57642.7% of flowCommon StockSEC:0001209191-23-002632:0
9,500 shares@ US$5.12100.0% of flowCommon StockSEC:0001415889-23-000705:0
919 shares@ US$19.57642.7% of flowCommon StockSEC:0001209191-22-054485:0
929 shares@ US$24.67453.3% of flowCommon StockSEC:0001209191-22-043097:0
907 shares@ US$33.114.8% of flowCommon StockSEC:0001209191-22-025523:0
3,684 shares@ US$24.882213.9% of flowCommon StockSEC:0001209191-22-004801:0
3,684 shares@ US$24.882211.9% of flowCommon StockSEC:0001209191-22-004801
11,973 shares@ US$19.1933.7% of flowCommon StockSEC:0001209191-21-056860:0
11,973 shares@ US$19.1928.7% of flowCommon StockSEC:0001209191-21-056860
14 of 14 declarations
About Cooper Ronald Harold Wilfred
Ronald Harold Wilfred Cooper is the President and CEO of ALBIREO PHARMA, INC. He leads the company and is responsible for implementing the overall strategy. Ronald plays a key role in directing operations and developing new pharmaceutical products.
